Wakefield Asset Management Lllp Dynavax Technologies Corp Transaction History

Wakefield Asset Management Lllp

  • $294 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024
BUY
$11.7 - $14.98 $4,750 - $6,081
406 Added 0.69%
59,637 $740,000
Q4 2023

Jan 25, 2024
BUY
$13.09 - $14.98 $775,333 - $887,280
59,231 New
59,231 $828,000
Q2 2021

Aug 10, 2021
SELL
$7.25 - $10.99 $609,732 - $924,269
-84,101 Closed
0 $0
Q1 2021

May 11, 2021
BUY
$4.57 - $11.18 $384,341 - $940,249
84,101 New
84,101 $827,000

Others Institutions Holding DVAX

# of Institutions
274
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Wakefield Asset Management Lllp Portfolio

Follow Wakefield Asset Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Wakefield Asset Management Lllp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email